Lv1
50 积分 2023-07-07 加入
Nilbert M, et al. for the ALASCCA Study Group. Low-dose aspirin for PI3K-altered localized colorectal cancer
10天前
已关闭
KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies
13天前
已完结
Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC: A Brief Report
13天前
已完结
Impact of co-mutations on the prognosis of targeted therapy in EGFR-mutant advanced NSCLC: A result of real-world study
13天前
已关闭
In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma
13天前
已完结
Targeted Therapy and Immunotherapy Lead to Rapid Regression of Advanced Non-Small Cell Lung Cancer with Multiple Driver Mutations
13天前
已完结
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy
13天前
已完结
KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies
14天前
已关闭
NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China
22天前
已完结
Precision navigation through the labyrinth: overcoming EGFR resistance in non-Small cell lung cancer
28天前
已完结
皖公网安备34019202002308
